1. Market Research
  2. > Healthcare
  3. > Health Facility Market Trends
  4. > 2015 Coagulation Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

2015 Coagulation Testing in US Hospitals, Commercial Laboratories and Point-of-Care/POC Locations

  • June 2015
  • -
  • Venture Planning Group
  • -
  • 455 pages

Summary

Table of Contents

Complete report $11,500.  DataPack (test volumes, sales forecasts, supplier shares) $7,500.


Summary


This comprehensive report contains 455 pages, 60 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the next five years. 


The report explores business and technological trends in the US coagulation testing market; provides leading supplier market shares estimates, as well as test volume forecasts for over 40 procedured performed in hospitals, commercial laboratories, physician offices, ER, OR, ICU, cancer clinics, ambulatory care center, surgery centers, nursing homes, and birth centers; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.


Strategic Recommendations


- Product development and business expansion

opportunities with significant market appeal.


- “Ideal” product models with tentative

prices and operating characteristics.


- Alternative market penetration

strategies for instrument and reagent suppliers.


- Potential market entry barriers and risks.


Coagulation Tests


Activated Clotting Time (ACT) (1), Activated Protein C Resistance,

Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time,

D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII,  Factor IX,

Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII,

Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation,

Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen,

Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S,

Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time,

Von Willebrand's Factor Fav/Ag, and others.


Sales and Market Share Analysis


- Sales and market shares of major

instrument and reagent suppliers.


Market Segmentation Analysis


- Comprehensive market

segmentation analysis, including:


Centralized Testing    

 

- Hospitals

- Commercial/Private Laboratories


POC/Decentralized Testing


- Physician Offices/Group Practices   

- Emergency Rooms       

- Operating/Recovery Suites     

- ICUs/CCUs

- Cancer Clinics       

- Ambulatory Care Centers       

- Surgery Centers

- Nursing Homes

- Birth Centers


- Test volume forecasts for over 40 major procedures

by market segment.


Current and Emerging Products


- Review of established and emerging procedures.


- Comparison of automated and semi-automated

analyzers from Diagnostica Stago, Helena, IL,

Siemens, Sysmex and other suppliers.


Technology Review


- Analysis of current and emerging technologies

and their potential market applications.


- Comprehensive lists of companies developing

or marketing new technologies and products by test.


Competitive Strategies


- Extensive strategic profiles of

major suppliers and emerging market entrants.


- The companies analyzed in the report include:


-  Abbott

-  ADI/American Diagnostica

-  Axis-Shield

-  Alere/Biosite/Inverness

-  Beckman Coulter/Danaher

-  Becton Dickinson

-  Bio/Data Corporation

-  Chrono-Log

-  Corgenix Medical

-  Diagnostica Stago/Trinity Biotech

-  Grifols

-  Helena Laboratories

-  Hyphen BioMed

-  Instrumentation Laboratory

-  ITC/Nexus Dx

-  Roche

-  Siemens

-  Sienco

-  Sysmex

-  Thermo Fisher

-  ZyCare/Alere

                                                                     

Contains 455 pages and 60 tables

This comprehensive report contains 455 pages, 60 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the next five years.

The report explores business and technological trends in the US coagulation testing market; provides leading supplier market shares estimates, as well as test volume forecasts for over 40 procedured performed in hospitals, commercial laboratories, physician offices, ER, OR, ICU, cancer clinics, ambulatory care center, surgery centers, nursing homes, and birth centers; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2017 Analysis of the Global Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

2017 Analysis of the Global Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

  • $ 28500
  • Industry report
  • March 2017
  • by Venture Planning Group

Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years- Examines trends in the U.S., Europe and Japan- Reviews current and emerging ...

2017-2021 World Tumor Marker Testing Market: Global Opportunities and Growth Strategies for Suppliers

2017-2021 World Tumor Marker Testing Market: Global Opportunities and Growth Strategies for Suppliers

  • $ 21100
  • Industry report
  • February 2017
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...

2017 Competing in the Global Cancer Diagnostics Market

2017 Competing in the Global Cancer Diagnostics Market

  • $ 21100
  • Industry report
  • March 2017
  • by Venture Planning Group

This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.